Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
239.92
-0.73 (-0.30%)
At close: Mar 9, 2026, 4:00 PM EDT
239.68
-0.24 (-0.10%)
After-hours: Mar 9, 2026, 7:35 PM EDT
Ascendis Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 14,726 | 13,089 | 8,234 | 7,125 | 6,824 | 7,635 | |
| Market Cap Growth | 56.97% | 58.97% | 15.57% | 4.41% | -10.63% | -15.23% | |
| Enterprise Value | 15,027 | 13,411 | 8,416 | 7,347 | 6,449 | 6,676 | |
| Last Close Price | 239.92 | 213.24 | 137.67 | 125.95 | 122.13 | 134.53 | |
| Forward PE | 45.82 | 94.73 | - | - | - | - | |
| PS Ratio | 17.42 | 15.48 | 21.87 | 24.17 | 124.77 | 863.17 | |
| PB Ratio | - | -68.47 | -75.24 | -44.24 | 24.25 | 7.60 | |
| P/TBV Ratio | - | - | - | - | 24.70 | 7.64 | |
| P/FCF Ratio | 278.84 | 245.48 | - | - | - | - | |
| P/OCF Ratio | 232.71 | 206.83 | - | - | - | - | |
| EV/Sales Ratio | 17.77 | 15.86 | 22.35 | 24.92 | 117.92 | 754.73 | |
| EV/FCF Ratio | 284.52 | 251.52 | - | - | - | - | |
| Debt / Equity Ratio | -5.35 | -5.35 | -8.10 | -4.42 | 1.93 | 0.12 | |
| Debt / FCF Ratio | 19.20 | 19.20 | - | - | - | - | |
| Net Debt / Equity Ratio | -1.57 | -1.57 | -2.81 | -1.68 | -0.89 | -0.77 | |
| Net Debt / EBITDA Ratio | -1.95 | -1.95 | -1.08 | -0.56 | 0.43 | 1.57 | |
| Net Debt / FCF Ratio | 5.63 | 5.63 | -0.97 | -0.52 | 0.46 | 1.55 | |
| Asset Turnover | 0.58 | 0.58 | 0.36 | 0.28 | 0.05 | 0.01 | |
| Inventory Turnover | 0.32 | 0.32 | 0.18 | 0.26 | 0.12 | - | |
| Quick Ratio | 0.72 | 0.72 | 0.81 | 0.62 | 1.06 | 7.03 | |
| Current Ratio | 1.04 | 1.04 | 1.17 | 0.95 | 1.29 | 8.03 | |
| Return on Equity (ROE) | - | - | - | -818.43% | -101.69% | -44.54% | |
| Return on Assets (ROA) | -6.86% | -6.86% | -17.38% | -29.73% | -32.29% | -27.35% | |
| Return on Capital Employed (ROCE) | -58.40% | -58.40% | -102.60% | -511.40% | -150.60% | -45.90% | |
| Earnings Yield | -1.82% | -2.05% | -4.75% | -7.47% | -9.13% | -5.71% | |
| FCF Yield | 0.36% | 0.41% | -3.87% | -7.29% | -7.99% | -6.57% | |
| Buyback Yield / Dilution | -4.69% | -4.69% | -2.85% | -0.38% | -2.37% | -8.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.